Mark Cockett in

Mark Cockett

Login to view DISC.
President & Chief Scientific Officer at Paratus Sciences
📍 New Haven, Connecticut, United States

Mark Cockett is the President and Chief Scientific Officer at Paratus Sciences, a company decoding evolution to develop new medicines. With over 30 years of experience, he has delivered numerous antiviral drugs to market, including atazanavir and entecavir. He holds a Ph.D. in molecular and cell biology from The Open University and is described by colleagues as a "great people leader" and one of the "smartest scientists" theyve worked with.

There is no publicly available information about his personal life or interests outside of his extensive professional career in the pharmaceutical and biotech industries. His work demonstrates a deep commitment to scientific discovery and addressing unmet medical needs through innovative research and development strategies.

He is leading research at Paratus Sciences that leverages the unique evolutionary traits of bats, such as their resistance to disease and cancer, to discover novel therapeutics for human diseases.

Read the full overview →
Experience
41 Years
Current Role
President & Chief Scientific Officer
Job Level
Leadership
Location
New Haven, Connecticut, United States
Personality Overview

How Mark shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Mark cares about

Bat-Inspired Therapeutics
His company, Paratus Sciences, is focused on translating the unique biological resilience of bats into first-in-class medicines for human diseases.
Antiviral Drug Discovery
He has a long and successful track record, having supported the development of multiple marketed antiviral drugs for HIV, HBV, and HCV.
+5 more topics Login to view topics
Career

Work history

4-2025
President & Chief Scientific Officer
Paratus Sciences
9-2024
Entrepeneur-In-Residence
Yale Ventures
5-2022 - 7-2024
CEO and President R&D
Alphina Therapeutics
3-2022
President
MIC Scientific Consulting
2-2016 - 2-2022
VP, Head of Discovery
ViiV Healthcare
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
Ph.D.
The Open University
Bachelor of Science - BS
Institute of Biology - Royal Society of Biology
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Mark. Free, 10 seconds.